PENNANT GROUP INC/THE (PNTG) Stock Fundamental Analysis

NASDAQ:PNTG • US70805E1091

31.97 USD
+0.81 (+2.6%)
At close: Feb 13, 2026
31.97 USD
0 (0%)
After Hours: 2/13/2026, 8:00:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

PNTG gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. PNTG has an average financial health and profitability rating. PNTG is valued quite expensive, but it does show an excellent growth. This makes PNTG very considerable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • PNTG had positive earnings in the past year.
  • In the past year PNTG had a positive cash flow from operations.
  • Each year in the past 5 years PNTG has been profitable.
  • Of the past 5 years PNTG 4 years had a positive operating cash flow.
PNTG Yearly Net Income VS EBIT VS OCF VS FCFPNTG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

  • With a decent Return On Assets value of 3.54%, PNTG is doing good in the industry, outperforming 67.65% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 8.29%, PNTG is in the better half of the industry, outperforming 67.65% of the companies in the same industry.
  • PNTG's Return On Invested Capital of 4.72% is in line compared to the rest of the industry. PNTG outperforms 55.88% of its industry peers.
  • PNTG had an Average Return On Invested Capital over the past 3 years of 3.91%. This is significantly below the industry average of 9.04%.
  • The last Return On Invested Capital (4.72%) for PNTG is above the 3 year average (3.91%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.54%
ROE 8.29%
ROIC 4.72%
ROA(3y)2.36%
ROA(5y)2.14%
ROE(3y)7.56%
ROE(5y)8.28%
ROIC(3y)3.91%
ROIC(5y)3.28%
PNTG Yearly ROA, ROE, ROICPNTG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

  • PNTG's Profit Margin of 3.15% is fine compared to the rest of the industry. PNTG outperforms 68.63% of its industry peers.
  • PNTG's Profit Margin has improved in the last couple of years.
  • The Operating Margin of PNTG (4.83%) is better than 63.73% of its industry peers.
  • PNTG's Operating Margin has improved in the last couple of years.
  • PNTG has a Gross Margin (20.13%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of PNTG has declined.
Industry RankSector Rank
OM 4.83%
PM (TTM) 3.15%
GM 20.13%
OM growth 3Y49.09%
OM growth 5Y24.56%
PM growth 3Y74.18%
PM growth 5Y34.45%
GM growth 3Y1.25%
GM growth 5Y-2.76%
PNTG Yearly Profit, Operating, Gross MarginsPNTG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PNTG is destroying value.
  • PNTG has more shares outstanding than it did 1 year ago.
  • PNTG has more shares outstanding than it did 5 years ago.
  • PNTG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PNTG Yearly Shares OutstandingPNTG Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
PNTG Yearly Total Debt VS Total AssetsPNTG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • PNTG has an Altman-Z score of 2.95. This is not the best score and indicates that PNTG is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a decent Altman-Z score value of 2.95, PNTG is doing good in the industry, outperforming 63.73% of the companies in the same industry.
  • The Debt to FCF ratio of PNTG is 0.93, which is an excellent value as it means it would take PNTG, only 0.93 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.93, PNTG belongs to the top of the industry, outperforming 89.22% of the companies in the same industry.
  • PNTG has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.08, PNTG is in the better half of the industry, outperforming 76.47% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.93
Altman-Z 2.95
ROIC/WACC0.53
WACC8.96%
PNTG Yearly LT Debt VS Equity VS FCFPNTG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

  • PNTG has a Current Ratio of 1.04. This is a normal value and indicates that PNTG is financially healthy and should not expect problems in meeting its short term obligations.
  • PNTG has a worse Current ratio (1.04) than 69.61% of its industry peers.
  • PNTG has a Quick Ratio of 1.04. This is a normal value and indicates that PNTG is financially healthy and should not expect problems in meeting its short term obligations.
  • PNTG has a worse Quick ratio (1.04) than 62.75% of its industry peers.
Industry RankSector Rank
Current Ratio 1.04
Quick Ratio 1.04
PNTG Yearly Current Assets VS Current LiabilitesPNTG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. Growth

3.1 Past

  • PNTG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.39%, which is quite good.
  • Measured over the past years, PNTG shows a very strong growth in Earnings Per Share. The EPS has been growing by 50.93% on average per year.
  • The Revenue has grown by 29.89% in the past year. This is a very strong growth!
  • The Revenue has been growing by 15.48% on average over the past years. This is quite good.
EPS 1Y (TTM)17.39%
EPS 3Y26.9%
EPS 5Y50.93%
EPS Q2Q%15.38%
Revenue 1Y (TTM)29.89%
Revenue growth 3Y16.5%
Revenue growth 5Y15.48%
Sales Q2Q%26.76%

3.2 Future

  • The Earnings Per Share is expected to grow by 18.92% on average over the next years. This is quite good.
  • Based on estimates for the next years, PNTG will show a very strong growth in Revenue. The Revenue will grow by 21.79% on average per year.
EPS Next Y25.69%
EPS Next 2Y18.77%
EPS Next 3Y18.92%
EPS Next 5YN/A
Revenue Next Year34.92%
Revenue Next 2Y29.34%
Revenue Next 3Y21.79%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PNTG Yearly Revenue VS EstimatesPNTG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
PNTG Yearly EPS VS EstimatesPNTG Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 29.60, which means the current valuation is very expensive for PNTG.
  • The rest of the industry has a similar Price/Earnings ratio as PNTG.
  • PNTG's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.97.
  • The Price/Forward Earnings ratio is 24.11, which indicates a rather expensive current valuation of PNTG.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of PNTG is on the same level as its industry peers.
  • PNTG's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.96.
Industry RankSector Rank
PE 29.6
Fwd PE 24.11
PNTG Price Earnings VS Forward Price EarningsPNTG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • PNTG's Enterprise Value to EBITDA is on the same level as the industry average.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as PNTG.
Industry RankSector Rank
P/FCF 39.71
EV/EBITDA 22.49
PNTG Per share dataPNTG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • PNTG's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • PNTG has a very decent profitability rating, which may justify a higher PE ratio.
  • PNTG's earnings are expected to grow with 18.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.15
PEG (5Y)0.58
EPS Next 2Y18.77%
EPS Next 3Y18.92%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • PNTG does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PENNANT GROUP INC/THE

NASDAQ:PNTG (2/13/2026, 8:00:00 PM)

After market: 31.97 0 (0%)

31.97

+0.81 (+2.6%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-05
Earnings (Next)03-04
Inst Owners95.38%
Inst Owner Change0.13%
Ins Owners4.71%
Ins Owner Change1.98%
Market Cap1.11B
Revenue(TTM)847.27M
Net Income(TTM)26.70M
Analysts87.69
Price Target36.55 (14.33%)
Short Float %2.67%
Short Ratio3.35
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.86%
Min EPS beat(2)-1.96%
Max EPS beat(2)5.67%
EPS beat(4)2
Avg EPS beat(4)3.3%
Min EPS beat(4)-1.96%
Max EPS beat(4)11.46%
EPS beat(8)5
Avg EPS beat(8)5.86%
EPS beat(12)7
Avg EPS beat(12)3.38%
EPS beat(16)8
Avg EPS beat(16)1.16%
Revenue beat(2)2
Avg Revenue beat(2)1.65%
Min Revenue beat(2)1.1%
Max Revenue beat(2)2.19%
Revenue beat(4)3
Avg Revenue beat(4)1.26%
Min Revenue beat(4)-0.34%
Max Revenue beat(4)2.19%
Revenue beat(8)7
Avg Revenue beat(8)2.77%
Revenue beat(12)11
Avg Revenue beat(12)3.01%
Revenue beat(16)14
Avg Revenue beat(16)2.5%
PT rev (1m)3.37%
PT rev (3m)8.59%
EPS NQ rev (1m)-0.45%
EPS NQ rev (3m)7.63%
EPS NY rev (1m)-0.14%
EPS NY rev (3m)7.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)14.19%
Revenue NY rev (1m)0%
Revenue NY rev (3m)5.24%
Valuation
Industry RankSector Rank
PE 29.6
Fwd PE 24.11
P/S 1.31
P/FCF 39.71
P/OCF 23.08
P/B 3.44
P/tB 28.41
EV/EBITDA 22.49
EPS(TTM)1.08
EY3.38%
EPS(NY)1.33
Fwd EY4.15%
FCF(TTM)0.81
FCFY2.52%
OCF(TTM)1.38
OCFY4.33%
SpS24.49
BVpS9.31
TBVpS1.13
PEG (NY)1.15
PEG (5Y)0.58
Graham Number15.04
Profitability
Industry RankSector Rank
ROA 3.54%
ROE 8.29%
ROCE 6.36%
ROIC 4.72%
ROICexc 4.74%
ROICexgc 8.48%
OM 4.83%
PM (TTM) 3.15%
GM 20.13%
FCFM 3.29%
ROA(3y)2.36%
ROA(5y)2.14%
ROE(3y)7.56%
ROE(5y)8.28%
ROIC(3y)3.91%
ROIC(5y)3.28%
ROICexc(3y)4%
ROICexc(5y)3.33%
ROICexgc(3y)6.26%
ROICexgc(5y)5.05%
ROCE(3y)5.26%
ROCE(5y)4.41%
ROICexgc growth 3Y73.2%
ROICexgc growth 5Y43.25%
ROICexc growth 3Y62.52%
ROICexc growth 5Y34.54%
OM growth 3Y49.09%
OM growth 5Y24.56%
PM growth 3Y74.18%
PM growth 5Y34.45%
GM growth 3Y1.25%
GM growth 5Y-2.76%
F-Score7
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.93
Debt/EBITDA 0.53
Cap/Depr 250.49%
Cap/Sales 2.37%
Interest Coverage 17.4
Cash Conversion 97.82%
Profit Quality 104.32%
Current Ratio 1.04
Quick Ratio 1.04
Altman-Z 2.95
F-Score7
WACC8.96%
ROIC/WACC0.53
Cap/Depr(3y)260.04%
Cap/Depr(5y)213.36%
Cap/Sales(3y)2.47%
Cap/Sales(5y)2.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.39%
EPS 3Y26.9%
EPS 5Y50.93%
EPS Q2Q%15.38%
EPS Next Y25.69%
EPS Next 2Y18.77%
EPS Next 3Y18.92%
EPS Next 5YN/A
Revenue 1Y (TTM)29.89%
Revenue growth 3Y16.5%
Revenue growth 5Y15.48%
Sales Q2Q%26.76%
Revenue Next Year34.92%
Revenue Next 2Y29.34%
Revenue Next 3Y21.79%
Revenue Next 5YN/A
EBIT growth 1Y23.28%
EBIT growth 3Y73.69%
EBIT growth 5Y43.85%
EBIT Next Year48.58%
EBIT Next 3Y30.05%
EBIT Next 5YN/A
FCF growth 1Y92.21%
FCF growth 3YN/A
FCF growth 5Y46.34%
OCF growth 1Y99.77%
OCF growth 3YN/A
OCF growth 5Y32.7%

PENNANT GROUP INC/THE / PNTG FAQ

Can you provide the ChartMill fundamental rating for PENNANT GROUP INC/THE?

ChartMill assigns a fundamental rating of 5 / 10 to PNTG.


What is the valuation status of PENNANT GROUP INC/THE (PNTG) stock?

ChartMill assigns a valuation rating of 3 / 10 to PENNANT GROUP INC/THE (PNTG). This can be considered as Overvalued.


Can you provide the profitability details for PENNANT GROUP INC/THE?

PENNANT GROUP INC/THE (PNTG) has a profitability rating of 6 / 10.


How financially healthy is PENNANT GROUP INC/THE?

The financial health rating of PENNANT GROUP INC/THE (PNTG) is 5 / 10.


What is the expected EPS growth for PENNANT GROUP INC/THE (PNTG) stock?

The Earnings per Share (EPS) of PENNANT GROUP INC/THE (PNTG) is expected to grow by 25.69% in the next year.